Abivax SA (AAVXF)
139.00
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Abivax EPS Diluted (Quarterly) : -0.7181 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.7181 |
| December 31, 2025 | -1.215 |
| September 30, 2025 | -2.457 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.865 |
| March 31, 2025 | -0.8697 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Poxel SA | -- |
| OSE Immunotherapeutics SA | -- |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.70M |
| Total Expenses (Quarterly) | 56.70M |
| Enterprise Value | 10.49B |
| Earnings Yield | -3.78% |
| Normalized Earnings Yield | -3.331 |